Background -Bronchial hyperreactivity to methacholine is present in children with asthma and other types of paediatric chronic obstructive pulmonary disease (COPD), while hyperreactivity to exercise is more specific for asthma. Adenosine 5'-monophosphate (AMP) is a potent bronchoconstrictor and, like exercise, may provoke asthma by activating mast cells. This study investigated the suitability of AMP as a specific challenge for asthma in children. Methods -Bronchial provocation challenges with methacholine and AMP were performed in a double blind fashion using tidal breathing in 51 children with asthma, 21 with paediatric COPD ofvarious types, and in 19 control children. Each subject also underwent a standardised exercise challenge after inhalation challenges were completed. Sensitivity and specificity curves were constructed and the intersection point of sensitivity and specificity for each type ofchallenge was determined. Results -When the asthmatic patients were compared with the children with COPD, the intersection points for AMP, exercise and methacholine were 90%, 85%, and 50%, respectively. When compared with the controls the same intersection points were 98%, 84%, and 92%, and when children with paediatric COPD were compared with controls they were 55%, 50%, and 82%. Conclusions -Methacholine distinguishes both asthma and paediatric COPD from controls with a sensitivity of 82-92%, but does not distinguish between asthma and paediatric COPD; exercise and AMP distinguish asthma from controls with a sensitivity and specificity of 84-98% but they also distinguish asthma from paediatric COPD with a sensitivity and specificity of 85-90%. AMP inhalation is a practical aid for diagnosing asthma and distinguishing it from COPD in children of all ages. (Thorax 1995;50:51 1-516) 
Bronchial hyperreactivity to methacholine or histamine is a characteristic feature of asthma.'-' Other chronic lung diseases, especially those associated with chronic infection, may also be associated with increased methacholine reactivity." However, in adult patients with chronic infections, bronchial hyperreactivity by cold air or isocapnic hyperventilation has been found in a minority of the patients.9'0 Moreover, we have recently shown" that children with asthma and those with chronic lung disease have hyperreactivity to methacholine, but only those with asthma are hyperreactive to physical exercise.
The pathophysiology of exercise-induced asthma is still disputed but there is increasing evidence of mediator release being involved. Exercise is associated with significant increases in plasma histamine and neutrophil chemotactic activity'2"15 which have been considered markers for the release of mediators by mast cells.'6'7 Adenosine is a potent bronchoconstrictor in asthmatic patients, possibly by stimulating or enhancing the release of mediators from mast cells.'819 Adenosine has been shown to potentiate the release of preformed but not newly generated mediators from mouse bone marrow-derived mast cells in tissue culture20 and has also been used for bronchial challenge in asthmatic patients.21-23 Thus, both exercise and adenosine may induce bronchoconstriction by releasing mediators from airway mast cells. Oosterhoff et a124 compared adults with chronic obstructive pulmonary disease (COPD) with adult asthmatic patients and found that non-smoking adults with COPD were less responsive to adenosine than to methacholine, while the asthmatic patients were similarly responsive to both. They did not study the response to exercise or hyperventilation.
The differentiation of asthma from other types of COPD can be difficult in children since the clinical picture can be very similar. In the present study we have compared bronchial challenges by exercise, methacholine, and adenosine 5'-monophosphate (AMP) in children and young adults with bronchial asthma, in young patients with chronic obstructive lung diseases, and in healthy subjects of similar age. The object of the study was to determine whether AMP, like exercise, was a more specific stimulus than methacholine in differentiating asthma from chronic obstructive lung diseases in such patients.
Methods

SUBJECTS
Ninety one children and young adults aged [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] years participated in the study; 51 met the during the four weeks before the studies in any of the subjects. At study entry all the control subjects and all but 10 patients (two with asthma, four with bronchiolitis obliterans, two with cystic fibrosis, one with bronchiectasis, and one with primary ciliary dyskinesia) had a forced expiratory volume in one second (FEVI) above 70% of the predicted value. All patients avoided bronchodilator therapy for at least 12 hours and sodium cromoglycate for at least 20 hours before the study. Inhaled corticosteroid therapy was continued unchanged. None of the 72 subjects was treated with theophyllinerelated compounds. The study was approved by the local ethics committee and written informed consent was obtained from the older subjects or from one parent.
STUDY DESIGN
The three challenges were performed on the same day in 55 patients (86%), within seven days in 78 patients (86%), and within 15 days in 86 patients (95%). In the five remaining subjects the challenges were performed within 30 days. The inhalation challenges were always performed in random order on the same day. When the exercise challenge was also performed on the same day as the inhalation challenge it was always the last challenge of the day. The exercise test was performed on a separate day in 16 subjects and on the same day as one of the inhalation challenges in 20 subjects. The interval between challenges on any one day was 2-5-3 hours which allowed the FEV1 to return to within 10% of baseline value of the first challenge in every case before the second and third challenges were per- methacholine or log AMP concentration. If the fall in FEVy was less than 10% at the maximal concentration, the next doubling values -that is, 64 mg/ml for methacholine and 800 mg/ml for AMP -were arbitrarily taken as PC20.
The exercise challenge was carried out using six minutes of treadmill running as described previously.26 The treadmill was set at a slope of 100 and the subjects ran continuously at a speed of 5 km/h. This produced a heart rate of 160-180/min and represented approximately two thirds of the maximal working capacity. FEV1 was measured before and 3, 5, 10, and 15 minutes after exercise. The challenge was performed in an air conditioned laboratory and the subjects breathed room air with a temperature of 22-260C and a relative humidity of 48-56%. Individual results for the three challenges in the three groups are shown in figs 1-3. It can be seen that in the control group 11 subjects (58%) failed to respond to the highest concentration of methacholine used and 16 subjects (84%) failed to respond to the highest concentration ofAMP. In the paediatric COPD group all responded to methacholine but 15 subjects (71%) failed to respond to AMP. In the asthmatics all but one subject responded to methacholine and all but one (not the same subject) to AMP. By its nature the exercise challenge provided a result in every case even if there was a small rise (negative fall) in 
value. In two previous studies"28 performed in our laboratory on 52 and 182 asthmatic children the upper limits (least reactivity) of methacholine responsiveness (using log mean + 2 log SD) were 4-4 and 7-7 mg/ml, respectively.
In the present study the upper limit of PC20 for methacholine (log mean + 2 log SD) in the asthmatic group was 5-6 mg/ml. Although a few of the control group had PC20 values below this range, the analysis of sensitivity and specificity (table 2) showed that, in concurrence with our previous study, " methacholine was useful in distinguishing the asthmatic subjects from the controls but not in differentiating between asthma and other types of chronic obstructive lung disease in children.
Exercise-induced bronchoconstriction has also been regarded as an important hallmark of asthma, but the percentage fall in FEVy taken as the cut-off limit for asthma in the literature ranges from about 10% to 20%.29 M Burr and coauthors32 studied a group of 812 children aged 12 years who were healthy and unrelated to asthmatic subjects and found that 92% had a fall in peak expiratory flow rate after exercise of less than 10%. In our previous study" the upper limit of percentage fall in FEV, in control children (taken as mean + 2SD) was 8&2% and in the present study it was 6-0%.
In the present study 40 of the 51 asthmatic subjects (78%) had a fall in FEV, of more than 6-0% while only one of the patients with paediatric COPD showed significant bronchoconstriction after exercise. This is very similar to the results of our previous study where none of the 22 children with paediatric COPD responded to exercise by bronchoconstriction." The inhalation challenges were performed randomly but the exercise test was performed at the end of the day in most cases. There is a slight possibility that the inhalation challenges might have influenced the exercise test. However, the protocol was identical for the different groups of patients and therefore, if there was any effect of one challenge on the response of the other, it would be the same in the three groups. From table 2 it can be seen that the intersection ofsensitivity and specificity for exercise was a little less than for methacholine in distinguishing the asthmatic from the control subjects, but it was much greater in distinguishing asthma from paediatric COPD.
There is a problem in the evaluation of the mean PC20 of the paediatric COPD and control groups since we may have underestimated the true PC20 of the non-responders and the assumed values taken for statistical analysis were the least values for PC20. Given these restrictions, the significance of the very large differences in the responses of the various groups is almost certainly underestimated.
The response of patients with paediatric COPD to AMP and exercise was poor or nonexistent up to the highest concentration used in the challenge. These subjects had lower basal lung function but, since they responded very well to methacholine, this could not have accounted for their lack of response to AMP and exercise. As a further check on the possible effect ofbaseline lung function we selected nine children with asthma and nine with paediatric COPD who were matched for age (11 e 16 (3 2) and 11 7 (3 2) years, respectively) and for baseline FEV1 (89-3 (10-0)% and 88-2 (8-9)%, respectively). There was no significant difference in the geometric mean PC20 to methacholine (0-29mg/ml (range 0-14-0 6) for paediatric COPD and 0 47 mg/ml (range 0-31 to 0 72) for asthmatics), while there was a significant difference for mean percentage fall in FEV1 after exercise (1-7 (3 0)% in those with paediatric COPD and 20-6 (18-5)% in asthmatics, p<001) and for geometric mean PC20 to AMP (257-3mg/ml (range 148-8-444 9) for patients with paediatric COPD and 6-35 mg/ml (range 5 06-7-97) for asthmatics, p<00001). These results closely reflect those of the whole groups so that baseline lung function was not the cause of the differences in response. In all but two asthmatic patients, whenever the exercise challenge was positive (>6.0% fall in FEVI), there was hyperreactivity to AMP at a concentration below the mean + 2SD of the asthmatic group (98-2mg/ml). On the other hand, 12 of the 49 asthmatic patients with a positive AMP challenge failed to respond to exercise. The mean PC20 of these 12 asthmatic children compared with that of the 39 children positive to exercise was not significantly different either for methacholine or AMP. These observations are reflected in the greater intersection point of AMP (98%) compared with exercise (84%) in distinguishing asthma from controls (table 2) . The reason for this is unclear but could be related to the multiple factors known to influence the response of asthmatic patients to exercise at any one time. 33 Adenosine challenge has clear advantages over exercise in that it can be performed in patients of all ages including the very young and older subjects in whom an exercise challenge would be undesirable. Moreover, the present study shows adenosine to be as specific as exercise in differentiating asthma from paediatric COPD, but more sensitive than exercise in revealing bronchial hyperreactivity in asthmatic subjects. Adenosine challenge should therefore be a very useful tool in the differential diagnosis of asthma and COPD in patients of all ages in whom the diagnosis is clinically uncertain.
In conclusion, our control group was insensitive to AMP, exercise and low concentrations of methacholine. Asthmatic subjects were responsive to all three challenges while patients with paediatric COPD mainly responded to methacholine. These findings suggest a final common pathway of hyperreactivity to methacholine in all types of chronic lung disease in children, including asthma, while a more specific and possibly mast cell-related pathway may exist only in asthmatic subjects. Adenosine, like exercise, is of much more value than methacholine in the differentiation of asthma from COPD in children. These inhalation challenges, unlike exercise, are suitable for virtually all age groups and seem to be a useful tool in the differential diagnosis of asthma in children and young people.
